282 related articles for article (PubMed ID: 18370590)
1. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.
Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Heneine W; Folks TM; Butera S; Otten RA
AIDS Res Hum Retroviruses; 2008 Apr; 24(4):543-6. PubMed ID: 18370590
[TBL] [Abstract][Full Text] [Related]
2. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.
García-Lerma JG; Otten RA; Qari SH; Jackson E; Cong ME; Masciotra S; Luo W; Kim C; Adams DR; Monsour M; Lipscomb J; Johnson JA; Delinsky D; Schinazi RF; Janssen R; Folks TM; Heneine W
PLoS Med; 2008 Feb; 5(2):e28. PubMed ID: 18254653
[TBL] [Abstract][Full Text] [Related]
3. Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis.
Curtis KA; Kennedy MS; Luckay A; Cong ME; Youngpairoj AS; Zheng Q; Smith J; Hanson D; Heneine W; Owen SM; García-Lerma JG
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):355-62. PubMed ID: 21637113
[TBL] [Abstract][Full Text] [Related]
4. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW
Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971
[TBL] [Abstract][Full Text] [Related]
5. A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity.
Ross TM; Pereira LE; Luckay A; McNicholl JM; García-Lerma JG; Heneine W; Eugene HS; Pierce-Paul BR; Zhang J; Hendry RM; Smith JM
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1072-81. PubMed ID: 24914761
[TBL] [Abstract][Full Text] [Related]
6. Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.
Kersh EN; Luo W; Zheng Q; Adams DR; Hanson D; Youngpairoj AS; Cong ME; Butler K; Hendry RM; McNicholl JM; Heneine W; Garcia-Lerma JG
J Infect Dis; 2012 Sep; 206(5):770-9. PubMed ID: 22740713
[TBL] [Abstract][Full Text] [Related]
7. Double oral administration of emtricitabine/tenofovir prior to virus exposure protects against highly pathogenic simian/human immunodeficiency virus infection in macaques.
Nakasone T; Murakami T; Yamamoto N
Jpn J Infect Dis; 2012 Jul; 65(4):345-9. PubMed ID: 22814162
[TBL] [Abstract][Full Text] [Related]
8. T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis.
Kersh EN; Adams DR; Youngpairoj AS; Luo W; Zheng Q; Cong ME; Aung W; Mitchell J; Otten R; Hendry RM; Heneine W; McNicholl J; Garcia-Lerma JG
PLoS One; 2011 Apr; 6(4):e19295. PubMed ID: 21541293
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.
Cong ME; Mitchell J; Sweeney E; Bachman S; Hanson DL; Heneine W; García-Lerma JG
J Infect Dis; 2013 Aug; 208(3):463-7. PubMed ID: 23633402
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
Metzner KJ; Binley JM; Gettie A; Marx P; Nixon DF; Connor RI
Retrovirology; 2006 Dec; 3():97. PubMed ID: 17184540
[TBL] [Abstract][Full Text] [Related]
11. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
[TBL] [Abstract][Full Text] [Related]
12. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.
Parikh UM; Dobard C; Sharma S; Cong ME; Jia H; Martin A; Pau CP; Hanson DL; Guenthner P; Smith J; Kersh E; Garcia-Lerma JG; Novembre FJ; Otten R; Folks T; Heneine W
J Virol; 2009 Oct; 83(20):10358-65. PubMed ID: 19656878
[TBL] [Abstract][Full Text] [Related]
13. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.
Tsegaye TS; Butler K; Luo W; Radzio J; Srinivasan P; Sharma S; Aubert RD; Hanson DL; Dobard C; Garcia-Lerma JG; Heneine W; McNicholl JM; Kersh EN
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):385-94. PubMed ID: 25886925
[TBL] [Abstract][Full Text] [Related]
14. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.
Rosenwirth B; ten Haaft P; Bogers WM; Nieuwenhuis IG; Niphuis H; Kuhn EM; Bischofberger N; Heeney JL; Uberla K
J Virol; 2000 Feb; 74(4):1704-11. PubMed ID: 10644340
[TBL] [Abstract][Full Text] [Related]
16. Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis.
Zheng Q; Ruone S; Switzer WM; Heneine W; García-Lerma JG
Retrovirology; 2012 May; 9():40. PubMed ID: 22571771
[TBL] [Abstract][Full Text] [Related]
17. Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection.
Massud I; Mitchell J; Babusis D; Deyounks F; Ray AS; Rooney JF; Heneine W; Miller MD; García-Lerma JG
J Infect Dis; 2016 Oct; 214(7):1058-62. PubMed ID: 27465645
[TBL] [Abstract][Full Text] [Related]
18. The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.
Van Rompay KK; Singh RP; Brignolo LL; Lawson JR; Schmidt KA; Pahar B; Canfield DR; Tarara RP; Sodora DL; Bischofberger N; Marthas ML
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):900-14. PubMed ID: 15220696
[TBL] [Abstract][Full Text] [Related]
19. Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge.
Lifson JD; Piatak M; Cline AN; Rossio JL; Purcell J; Pandrea I; Bischofberger N; Blanchard J; Veazey RS
J Med Primatol; 2003 Aug; 32(4-5):201-10. PubMed ID: 14498980
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.
Cong ME; Pau CP; Heneine W; García-Lerma JG
PLoS One; 2016; 11(11):e0164821. PubMed ID: 27806064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
